Trial Information

Summary: Prevention of Recurrent Hepatitis B After Liver Transplantation

Status: Completed

Protocol Number: MCT00059267

Sponsor:

Company Division: Diagnostic

Official Scientific Title: Prevention of recurrent hepatitis B after liver transplantation

Brief Summary: This study is designed to determine risk factors for recurrent HBV post-liver transplantation, and to determine optimal prophylactic therapy to prevent HBV recurrence.

Study Phase: N/A

Study Design / Study Details:

• Purpose:
• Allocation: Non-Randomized
• Masking: Open Label
• Control: Uncontrolled
• Assignment: Single Group
• Endpoints:

Study Type:

Condition: Hepatitis B, Chronic

Intervention Type: Diagnostic Test

Intervention Name: CA HBV MONITOR RUO

Primary Outcome:

Key Secondary Outcomes:

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 13 Years Max: 100 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: January, 2002

Trial Registration Date: 03/17/2006

Date Last Updated: 02/07/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 2, 2008 at 2:12:37 PM